Tag: Technical Analysis

  • How to Use Technical and Fundamental Analysis Together

    How to Use Technical and Fundamental Analysis Together

    Introduction

    Understanding what to buy and when to buy it is important when investing in the stock, particularly if your objective is steady income. Technical analysis and Fundamental analysis are two of the most effective methods used by investors. Each provides insightful information on its own. However, when combined, they can offer you a comprehensive competitive advantage.

    This article examines how income-focused investors can avoid expensive entry points, find solid dividend-paying stocks, and create a dependable income-generating portfolio by combining technical and fundamental analysis. We’ll also show you how to use the Stocks Telegraph Screener to implement these tactics.

    Fundamental Analysis (Intro)

    A company’s long-term worth and financial stability are examined by fundamental analysis. Income investors, who depend on a company’s capacity to maintain and increase dividend payments over time, should pay particular attention to this.

     Important factors to look at:

    Dividend yield & payout ratio help you understand whether the dividend can be sustained.
    Earnings Per Share (EPS) gives an idea of whether profits show a steady upward trend.
    Free cash flow tells if there is sufficient money available to pay dividends.
    Debt-to-equity ratio shows whether the business has too much debt.
    P/E, P/B, and PEG valuation metrics show if the stock is undervalued or overvalued.

    These metrics help you understand: “Is this company financially strong and worth owning for the long term?”

    Technical Analysis (Intro)

    Technical analysis primarily concentrates on chart patterns, trading volume, and price action. It helps traders make decisions, when to purchase or sell stocks.

    Important Factors to keep an eye on:

    • 50-day, 200-day moving averages show trends and possible entry points.
    • The Relative Strength Index (RSI) tells if a stock is overbought or oversold.
    • MACD (Moving Average Convergence Divergence) highlights momentum changes
    • Support & Resistance Levels identify entry or exit zones

    In short, this side of the analysis tells whether it is now a good time to enter or wait for a better price.

    Why Income Investors Should Combine Both

    Relying only on fundamentals can lead you to buy good companies at bad times (e.g., during a price dip). Meanwhile, using only technicals may cause you to trade based on momentum, missing the long-term income potential of a stock.

    When used together:

    • Fundamentals help you choose what to invest in.
    • Technicals help you decide when to invest.

    If you use them together, it ensures you’re picking high-quality dividend stocks at the right time, maximizing income, and minimizing downside.

    How to Use Both Together – Step-by-Step

    Let’s walk through a real-world income-investing scenario:

    Step 1: Use the Stocks Telegraph Screener for Fundamentals

    Go to the Stocks Telegraph Screener and apply filters like:

    • Dividend Yield ≥ 4%
    • Payout Ratio ≤ 60%
    • Free Cash Flow Positive
    • P/E Ratio ≤ 15
    • Debt/Equity ≤ 1

    This will give you a list of financially solid dividend stocks. You’ve now screened for companies that can sustain income payouts.

    Step 2: Pull Up the Stock Chart for Technical Analysis

    After finding a strong fundamental pick, use any free charting platform (e.g., TradingView, Yahoo Finance) and look for:

    • RSI—If it’s below 30, the stock might be oversold (good entry point).
    • Moving Averages—Look for the stock trading above the 50-day MA (bullish trend).
    • MACD Crossover—A bullish crossover could signal a momentum shift.
    • Support Level—Is the stock bouncing off a key support zone?

    If the stock is fundamentally strong and technically positioned for a bounce or rally, you’ve found a potential gem.

    Example: Combining Both Analyses

    Let’s say you find Pfizer (PFE) on the Stocks Telegraph Screener:

    • Dividend Yield: 6.0%
    • Payout Ratio: 60%
    • Free Cash Flow: Strong
    • Debt Levels: Manageable

    Now you check the chart:

    • RSI is 32 (approaching oversold)
    • The price is near the 52-week support
    • MACD shows a bullish crossover

    Conclusion? It could be a solid dividend pick with a smart entry point.

    Tip for Investors

    Dividend Reinvestment Plans (DRIPs) can be a very good choice if you are using this strategy for long-term income growth. It enables your dividends to compound your income over time by automatically purchasing additional shares.

    Watch Out for These Pitfalls
    • Don’t buy just because the technicals look good. Check the fundamentals first.
    • Don’t ignore valuation. A high dividend yield could be a red flag if earnings are declining.
    • Technical indicators aren’t always accurate—combine multiple signals before making a decision.
    Tools to Make This Easier
    Tool Use
    Stocks Telegraph Screener Filter stocks with strong dividends & fundamentals
    Yahoo Finance View financials, charts, and analyst ratings
    TradingView Deep technical charting with custom indicators
    Morningstar For dividend safety ratings & stock valuation

    Final Thoughts: Best of Both Worlds

    As an income-focused investor, you’re not just chasing flashy price swings — you’re building a consistent cash flow stream. But that doesn’t mean you should ignore timing.

    By blending technical and fundamental analysis, you can:

    • Avoid weak or risky dividend traps
    • Buy high-quality stocks at favorable prices
    • Build an income stream that grows and compounds over time

    Use the Stocks Telegraph Screener to start building your watchlist today—and make smarter, more strategic investment moves.

  • Is XERS Stock a Good Buy in 2025? Key Insights for Investors

    Is XERS Stock a Good Buy in 2025? Key Insights for Investors

    Xeris Biopharma Holdings (NASDAQ: XERS) has been gaining attention in the biotech industry due to its innovative drug pipeline and strong growth potential. As investors look toward 2025, many are wondering: Is XERS stock a good buy in 2025? This article explores Xeris’ business model, financials, growth drivers, risks, and expert opinions to help you determine if it’s a solid investment.

    Xeris Biopharma Overview & Business Model

    Xeris Biopharma is a biotech company specializing in ready-to-use injectable drug formulations that improve patient adherence and reduce the need for refrigeration. Its proprietary XeriSol™ and XeriJect™ technology platforms enhance the stability and delivery of various biologics and small molecules.

    Key Revenue Sources:

    • Gvoke HypoPen (glucagon for severe hypoglycemia treatment)
    • Keveyis (the first FDA-approved treatment for primary periodic paralysis)
    • Recorlev (for Cushing’s syndrome)
    • Partnerships and licensing agreements with pharmaceutical companies

    XERS Stock Performance & Financial Analysis

    Stock Snapshot:

    • Current Price: $5.03
    • 52-Week Range: $1.69 – $5.07
    • Market Cap: $774.32M
    • P/E Ratio: -13.55
    • EPS (TTM): -$0.37
    • Revenue (TTM): $182.68 million

    Financial Highlights – Q2 (Dec 2024) Report:

    • Revenue: $60.099 million (35.39% YoY growth)
    • Net Income: -$5.11 million (61.81% YoY improvement)
    • Diluted EPS: -$0.03
    • Cash & Equivalents: $71.62 million
    • Debt-to-Equity Ratio: -1.84

    Xeris has demonstrated strong revenue growth, fueled by increasing product adoption. However, profitability remains a challenge, primarily due to continued investments in R&D and operational expansion. The company’s financials indicate a steady trajectory toward reducing losses, a critical factor for investors evaluating long-term potential.

    Growth Drivers for XERS Stock in 2025

    Expanding Drug Pipeline

    • Xeris is advancing multiple clinical trials targeting endocrinology, neurology, and metabolic disorders.
    • Potential FDA approvals and label expansions in 2025 could drive revenue growth.

    Strategic Partnerships & Licensing Deals

    • Collaborations with big pharma companies could unlock new revenue streams.
    • Licensing out its XeriSol™ and XeriJect™ platforms may generate milestone payments.

    Rising Demand for Ready-to-Use Injectables

    • The biopharmaceutical industry is shifting toward patient-friendly drug delivery methods.
    • Xeris’ innovative formulations provide a competitive edge over traditional injectable medications.

    Potential Risks & Challenges

    Regulatory & Clinical Trial Risks

    • Any delays or failures in FDA approvals could negatively impact stock performance.

    Financial Sustainability

    • Xeris is not yet profitable, relying on external funding and debt to support operations.

    Competition from Larger Biotech Firms

    • Companies like Eli Lilly (LLY) and Novo Nordisk (NVO) dominate the diabetes and endocrinology market.
    • Xeris must differentiate its products to capture market share.

    Analyst Ratings & Price Target Predictions

    XERS Recent Analyst Ratings: Strong Bullish Sentiment

    Analysts remain optimistic about Xeris Biopharma Holdings (XERS), with several firms raising their price targets and maintaining bullish ratings. The latest analyst ratings suggest strong growth potential, reflecting confidence in the company’s expanding product pipeline and revenue trajectory.

    Latest Analyst Ratings – March 7, 2025

    • Roanna Ruiz (Leerink Partners): Maintains an Outperform rating, raising the price target from $5.00 to $6.00, indicating potential upside.
    • Oren Livnat (HC Wainwright & Co.): Reiterates a Buy rating, with an aggressive price target jump from $6.60 to $8.00, reflecting strong conviction in Xeris’ growth outlook.
    • David Amsellem (Piper Sandler): Reiterates a Neutral rating, adjusting the price target from $3.00 to $4.00, signaling a cautious stance despite some upside.
    • Chase Knickerbocker (Craig-Hallum): Maintains a Buy rating, increasing the price target from $5.00 to $6.50, reinforcing a positive long-term outlook.

    The analyst consensus suggests a bullish trajectory for XERS stock, with multiple firms raising their price targets. While some remain cautious, the upward revisions indicate confidence in Xeris’ future performance, making it a compelling watchlist candidate for 2025.

    Institutional & Retail Investor Sentiment

    Institutional Ownership: Who’s Backing Xeris Biopharma (XERS)?

    Institutional investors play a crucial role in shaping market sentiment, and Xeris Biopharma Holdings (XERS) has gained solid backing from major financial institutions. Currently, 42.87% of XERS shares are held by institutional investors, reflecting strong confidence in the company’s prospects.

    Top Institutional Investors

    • Principal Financial Group Inc. leads the pack, holding 89.62K shares valued at $198.06K, representing a 0.06% stake in Xeris Biopharma.
    • AllianceBernstein L.P. follows closely, with 80.42K shares valued at $177.73K, also translating to a 0.06% stake in the company.

    Investor Sentiment on Xeris Biopharma (XERS) – What’s the Market Saying?

    Investor sentiment plays a critical role in determining short-term price movements, and Xeris Biopharma (XERS) stock has seen shifting sentiment trends over different timeframes.

    Short-Term Sentiment (1 Week & 1 Month)

    • The one-week sentiment score currently stands at 5.26, reflecting data from 22 social media posts but no news articles or opinion pieces.
    • This marks a significant decline of -15.78 points from 21.04 a week ago, indicating a drop in positive discussions surrounding XERS.
    • Over the past month, the sentiment trend has mirrored this movement, with the score falling from 21.04 to 5.26.
    • The sentiment score has fluctuated between 5.26 and 33.1 over the past month.

    Mid-Term Sentiment (6 Months)

    • The six-month sentiment score presents a more optimistic picture, currently at 39.2.
    • This figure is derived from 127 social media posts, 4 news articles, and 1 opinion article, reflecting higher investor engagement over the long term.
    • The sentiment score has ranged between 0 and 53.43, showing broad fluctuations in investor perception.

    The Verdict: Should You Buy, Hold, or Sell XERS Stock in 2025?

    With all the data analyzed—including financial performance, institutional ownership, sentiment trends, and analyst ratings—let’s break down whether Xeris Biopharma Holdings (XERS) stock is a buy, hold, or sell in 2025.

    Bullish Case: Why XERS Stock Could Be a Strong Buy

    Revenue Growth & Market Expansion
    Xeris reported strong YoY revenue growth of 35.39% in Q2 2024, indicating solid demand for its pharmaceutical products. Expanding partnerships and commercialization of innovative therapies could drive further revenue gains.

    Analyst Optimism & Price Target Upside
    Multiple analysts have maintained “Buy” or “Outperform” ratings on XERS stock, with price targets increasing from $5.00 to $8.00, indicating strong upside potential.

    Institutional Confidence
    Financial institutions hold 42.87% of XERS shares, with notable investors like Principal Financial Group and AllianceBernstein showing interest, which suggests institutional confidence in Xeris’ long-term growth.

    Potential for Profitability
    While Xeris still reports net losses, its reduced loss margins and higher gross revenue indicate the company is moving toward profitability. Continued cost management and revenue expansion could help Xeris break even sooner than expected.

    Bearish Case: Why XERS Stock May Face Challenges

    High R&D and Operating Costs
    Despite revenue growth, net losses remain a concern (-$5.11M in Q2 2024), primarily due to high research & development (R&D) and operational expenses. Investors should monitor whether Xeris can scale operations efficiently.

    Stock Volatility & Sentiment Decline
    Investor sentiment dropped significantly from 21.04 to 5.26 in one week, reflecting short-term uncertainty. This could indicate near-term price fluctuations and risk.

    Negative EPS & Valuation Concerns
    Xeris still has a negative EPS (-$0.03 diluted EPS) and a P/E ratio of -13.55, suggesting it is not yet profitable. The stock remains speculative for investors seeking consistent earnings.

    Final Recommendation: Buy, Hold, or Sell?

    • Buy if you are a long-term investor willing to tolerate volatility and believe in Xeris’ growth trajectory, revenue expansion, and future profitability.
    • Hold if you are waiting for profitability improvements and cost reductions before making a stronger commitment.
    • Sell if you prioritize stable, dividend-paying stocks or want to avoid speculative biotech investments.

    Conclusion: Is XERS Stock a Good Buy in 2025?

    Given Xeris Biopharma’s impressive revenue growth, strong analyst support, and institutional confidence, the stock presents an attractive long-term opportunity. However, its ongoing losses and stock volatility make it a riskier short-term investment. Investors seeking high-growth potential may consider buying, while those preferring stable returns should wait for further financial improvements.

  • Binance Coin (BNB) – What can we Expect?

    Binance coin known as BNB is one of the coins which has the most volume and has a very good potential in the coming time. The coin has been pretty much following the BTC movement, so a pretty same view would be for BTCUSDT.

    Starting from the higher time frame which is Monthly, the price has formed a double top. Right now the price is very much close to the Neckline of it and it has been rejected very often from that. Now talking about the mentality, many would be waiting for a break of that which would induce sellers in the market and price might very likely manipulate them. So from this perspective, there is a good chance that the price might push further down and do a stop hunt of the neckline.

    Moving down to the Weekly Time Frame, the price is showing a Wyckoff ReAccumulation schematic. The price at the moment seems to be unfolding a Spring or maybe sooner after grabbing liquidity. So following this perspective, it does have a little bit of potential to the downside, probably around 187$ from where a decent volume can be anticipated. As price needs fuel to move, liquidity is fuel for price. So as soon price grabs that, there shall/could be a good momentum.

    Moving down to the Daily Time Frame, the price has just recently tapped into the Fair Value Gap and showed a good bearish momentum. Overall talking about the macrostructure and momentum, both are bearish. The price hasn’t shown any structure shift to the upside, nor a good bullish momentum. So considering this, it’s reasonable to go with the flow.

    Talking about the 4 Hour Time Frame, the price is pretty much-showing weakness in sellers. In 4 Hours, the price was breaking structures to the topside, but as soon as it tapped the Daily fair value gap, the price did a change in character and a good bearish momentum emerged unfolding a shift in structure and momentum. Now recently price tapped into a demand zone and there is a possibility that it’ll keep pushing it to the upside for some time. If it drives back in the POI, LTF confirmations will be needed to get in for short positions.

    The invalidation point is above the structural HIGH and the target is around $272.

  • Convex Finance (CVX) – What is the Chart Showing Us?

    The price of CVX is about $20.80 at the CVX of writing, up 11 percent in a single day and the rest of the market is also in green. It is currently one of the top gainers. Today, the volume has climbed by over 136 percent. The overall new volume is estimated to be roughly $104 million.

    During this CVX, the low point was around $18.61 and the high point was around $30.10. According to the most recent data released by the coin market cap, the currency has risen to number 78th, indicating that it is on many traders’ watchlists.

    CVX reached a near-all-time high in December, hovering around $63. The CVX coin has a very small supply of roughly 100M coins. Around all percent have been distributed in the market, according to coinmarketcap. As a result of this small supply, CVX has become gained a huge price with just a small market cap as compared to other coins.

    Technical Analysis –  Convex Finance

    Moving down to the technical portion and starting from the Weekly Time Frame, for the past 6 weeks CVX has been printing bearish candles which have made a significant decrease in the value of the price. After this coin was launched on Binance, it went all the way up to $63.11, and afterward, it dropped hard till $16.21. Now as the price has an impulse down, on Lower Time Frame a correction of this wave can be expected.

    Nothing more on the Weekly Time Frame, so moving down to the Daily Time Frame, it can be seen that price has been creating Lower Lows and Lower Highs, but price recently unfolded a Pole Flag pattern and followed it very closely. Moreover adding to it, the price also completed an ABCD pattern which is a harmonic pattern. So seeing these two unfold, some counter-trend longs can be taken.

    CVX - 4H

    Jumping down to the 4 Hour Time Frame, It can be clearly seen that the price did a structure shift and flipped the last standing Supply Zone so now the Demand Zone is in control. The bullish momentum that emerged was extremely strong which left a lot of Imbalance within it. Now price is reaching the last Demand from where buys can be taken till $24.81

    Price Prediction – Convex Finance (CVX)

    CVX has been one of the market’s most optimistic coins. Despite the fact that the price of CVX has risen dramatically in just a few days. CVX is expected to reach a value of $63.017 in a year, according to the wallet investor. When compared to the current price of the coin, this is an increase. In five years, the price is expected to reach more than $239.705. However, traders are enthusiastic about the price movement and believe it will be worth much more in the future.

  • Curve Dao (CRV) – Will the Structure Stay Intact?

    At the time of writing, the price of CRV is about $2.71, up 8.68 percent in a single day, and the rest of the market is also up. It is now one of the leading gainers. Today, the volume has increased by more than 24%. The total additional volume is expected to be over $410 million.

    The low point of this CRV was approximately $2.47, while the peak point was around $2.74. According to the most current coin market cap statistics, the currency has surged to number 70, showing that it is on the radar of many traders.

    In August 2020, CRV achieved a near-all-time high, hovering around $23. The CRV coin has a total quantity of around 3.3 billion coins. According to coinmarketcap, around 14% has been dispersed in the market. As a result of the limited supply, CRV has risen in value despite having a lower market size in comparison to other coins.

    Technical Analysis –  Curve Dao(CRV)

    Starting the technical analysis of CRV from the Weekly Time Frame. Observing the Structures first, it can be seen that the macrostructure is to the upside and this bearish move is merely a Correction of that bullish Impulse. Plotting the Fibonacci from the last Low to the last high, the price seems to be in the Golden Ratio and within the Wick which contains Order Block on the Lower Time frame.

    CRV - 4H

    Nothing clear on The Daily, so on 4 Hour Time Frame, the price has clearly shifted structures to the topside, flipping the last Supply Zone. The Wyckoff Schematics as well seems completed, so on the Pullback longs can be taken all the way up to $2.9. Although it’s necessary to check out for confirmations on lower Time Frame

    Price Prediction – Curve Dao

    CRV has been one of the most bullish currencies in the market. Despite the fact that the price of the CRV has climbed drastically in a matter of days. According to wallet investor, CRV is anticipated to reach a value of $4.368 in a year. This is a rise when compared to the current price of the coin. The price is predicted to exceed $12.5954 in five years. Traders, on the other hand, are excited about the price fluctuation and feel it will be worth much more in the future.

  • Waves (WAVES) -Top Gainer and What Now?

    Waves after making its All-Time High, which was at $41.86, started breaking structures to the downside. The price has just Impulse to the upside after it was released. So a correction of this Impulse was necessary which is being unfolded right now. This is being observed on the Monthly Time Frame, so talking about the decrease in price, in the past 4 months Three bearish candles decreased the price of Waves by 88% while the last month was a gain of 78%. Now, this Bullish candle can be considered as a correction of the bearish wave which itself was a correction of the first wave which was bullish in nature after it was launched.

    Nothing more on the Monthly Time Frame, so moving down to the Weekly Time Frame. On Weekly Time Frame, first checking out the Structures, the structure is still to the downside. The price recently flipped the most recent Demand Zone, so probably the Supply Zone is in control. Checking out the Momentum, the price of Waves did push upwards and bullish momentum was seen but overall on a macro scale, the bearish Momentum still is very strong. While it was pushing down, 13 consecutive bearish candles were observed which shows a lot of strength bears had. Both, the Momentum and structure to the downside show that only shorts positions must be preferred. The Order Flow is to the downside, Most people after strong momentum get in the reversal which most of the time fails.

    WAVES - 1D

    Moving down to the Daily Time Frame instead of the 4 Hour time frame on Waves, because on 4 hours, there is nothing special, just a big pump which was most definitely due to the BTC influence. Now going over the Daily Time Frame, it can be seen that price recently tapped in a Hidden Order Block which was sitting within the wick. The price reacted off it beautifully. Below that there was Trendline Liquidity which got taken out and the price has now the necessary fuel. It can’t be ignored that price flipped a supply zone as well on a micro stage and also did a shift in the market structure below as it was unable to create a lower low. Talking about the invalidation point, if the level of $20.11 gets violated the whole scenario would get invalidated, while talking about the targets, the level of $13.36 can serve as a great one as the price can bounce from that as that is the last demand zone in control

  • Chiliz (CHZ) – What is the Chart Showing?

    Checking out the technical of CHZ and starting off with the Weekly Time Frame, the price on a macrostructure is still bullish, but that is not just important at all. Checking out the structures on a bit micro level, it can be observed that, price is still breaking structures to the downside, and making Lower Highs and Lower Lows. The last three weeks closed as bearish which shows that bears are still in control and might be able to push price downside to some more extent. Now the volume is not too much, but still, it can’t be ignored. Besides that, talking about this Impulse to the downside overall seems strong as well. So going with the Order Flow, it’s preferable to go with the short positions unless some sort of Wyckoff Accumulation is observed.

    Nothing more on the weekly Time Frame so moving one step down to the Daily Time Frame, it can be observed that after that previous push to the downside, price correctively pushed upside and after making another Lower High, its impulses to the downside again. Now at the moment, the price is not showing any reversal, and moreover talking about the harmonic ABCD pattern and Pole Flag Pattern, both seem completed for now. This shows that the price still has some strength to the downside.

    CHZ - 4H

    Moving down one more Time Frame which is the 4 Hour Time Frame, the price has some more confluences which shows that it has some potential to the downside. Talking about the structure firstly, that is entire to the downside even in this lower Time Frame. Now as the price was breaking structure to the downside, it flipped the Demand as well, so Supply is in control, and the price is still within that Supply Zone. Now it can’t be ignored that price once has touched that Supply Zone, and not a great reaction was seen from that even tho the momentum of bulls was just not strong. Now as the price is again at the same level so it’s quite possible that the price may do the Stop Hunt of the previous High and after grabbing the liquidity it may fall down. Price can be anticipated that the stop hunt may end with the previous Order Block which lies at $0.1931 from where shorts can be taken. Talking about the invalidation, if that level breaks this whole scenario will get invalidated, and talking about the target the level of $0.1551 may serve as a great one.

  • Binance Coin (BNB) – What is the Chart Showing Us?

    Binance Coin (BNB) – What is the Chart Showing Us?

    BNB overall is having a great price action as proper waves either impulse or corrective can be observed. BNB performed really well even with the BTC drop as the momentum with which BNB recently dropped was not too bad. Previously price recovered with momentum and the same can be expected this time as well

    Starting the technical analysis for BNB from the Weekly Time Frame, the price is around the previous low and can be considered in a Discount array that prefers buys only. The price of BNB along the way to the downside started losing momentum, and the last candle is probably going to close as a pin bar which is a reversal pattern at such zones. Now as the price has made a Low, the next move is Bullish Impulse is a formation of Higher High so this gives a bullish bias on Weekly Time Frame.

    BNB - 4H

    Moving down to the Daily Time Frame, as there’s not too much on the Weekly Time Frame, so on Daily, it can be seen that the last low was at $336.5 which recently got stop hunted. Previously after the last low, the price consolidated much which shows that previous bearish momentum is losing its strength. Within that consolidation, the price has formed a double top pattern which shows that there is a lot of liquidity above that pattern which may sooner drive the price upwards. Now in here, the previous day’s candle got severe rejections from the bottom which just took out the liquidity from the previous low and now the price has the necessary fuel needed to push to the upside. So this gives a bullish bias on the Daily Time frame as well for BNB

    Moving down to the last time frame which is the 4 Hour Time Frame, the price of BNB still hasn’t broken structure to the upside. Here there are two scenarios that may unfold for the buy bias. The first one is to wait for structural high to get broken, and on a pullback, the position can be taken. The second is a bit aggressive entry as there is a demand zone above, which may push price downside, and as there is an imbalance below, the price may push from there. Talking about invalidation, if the structural low gets broken, this whole scenario will get violated, and talking about that targets, the first target can be around $417.7 as that is an inefficiency zone

  • Avalanche (AVAX) – What does the Chart Show?

    Avalanche (AVAX) – What does the Chart Show?

    AVAX currently at the time of writing is being traded at the price of almost $80.26. In the past 24 hours, the price has increased by almost 9.77%. It is listed in the 10th spot on coinmarketcap according to market capitalization. The daily volume on the other hand has decreased by almost 7% in the last day. It has a market dominance of about 1.13%.

    Technical Analysis – Avalanche (AVAX)

    Moving to the technical analysis of AVAX, and starting from the Weekly Time Frame.

    Other than the recent candles anatomy, the other macrostructure is not very important at the moment, but still, the price has shifted structures in a sense that it failed to create another Higher High after it made a Higher Low and it broke that Higher Low and this seems to be a corrective wave of that huge impulse. The previous week, the candle closed as a DOJI which took out and stop hunting the previous weeks. Price this week is trying to mitigate the equilibrium of the previous week’s wick.

    Moving to the Daily Time Frame, the price seems to have shifted structures very clearly, it’s a complex pullback towards optimal trade entry-level.

    Moving to the 4 Hour Time Frame, the momentum is strong and has done some inducements which would induce early sellers which probably will be taken out. Price may push upside further, and mitigate the Order Block which is in confluence with FIBO golden ratio.

    Talking about the invalidation, if the price violates that OB which is the POI then this scenario will get invalidated, while talking about the target the level of $75.03 can act as a great one.

    Price Prediction – Avalanche

    AVAX has been one of the most bullish coins in the market among the high market cap coins. This can be seen as the all-time high of the coin lies around the price of almost $147. According to wallet investor, the price of AVAX is expected to reach a value of almost $184.199. In five years the price is expected to grow and reach a value of almost $594. This shows that the price can do multiple times from where it is right now.

  • Adventure Gold (AGLD) – What is the Chart Showing Us?

    Moving to the technical side of AGLD, and checking out the price action starting from Daily. The price recently tapped in the daily demand zone. Now, this demand zone was quite strong because for the demand zone to be strong, there are two things important. If the price of AGLD  leaves an imbalance and if the price breaks structure, then that is a valid and strong demand zone. Now besides that, the price emerged way much momentously which shows that buyers were really interested in that level. Now, this is how the demand level on a daily formed but the second important thing is the delivery of price within a zone. In this case, as it can be observed, the price when it was pulling back with weak momentum, and the wave was corrective in nature. This is very ideal if one is interested in taking trade from the zone

    AGLD - 4H

    Moving down to the 4 hours, starting from the structure first, the price of AGLD was breaking structures to the downside, but recently it failed to break the Low, and instead, it broke the recent Lower High, which shows the structure change in the price. Now, this structure shift was not a usual one rather a strong one, because it also flipped the recent Supply and now the Demand is in control. It can be clearly observed that when the price pulled back, the momentum was very much strong, but the demand in control held the price and acted as a support for the price. Moreover, the momentum which arose from the demand still was great which shows that bulls are dominant. Now, this also has a confluence of BTC as BTC movement affects the alts movement too much extent being the reason, it bounced because BTC also tapped in a daily order Block and reacted nicely of it. AGLD price has also left some liquidity above which acts as a magnet for price.

    Invalidation Points

    Now talk about the invalidation and targets points. Firstly the level of $0.855 can serve as an invalidation point because if that fails, the structure will change, the supply will be in control, which would favor only shorts. Talking about the target, the range between $1.215 to $1.246 serves as a great target because that is a retail resistance, and a pool of liquidity is sitting there which can drive the price towards it.